Original Research

CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer

Wang J, Che W, Wang W, Su G, Zhen T, Jiang Z

Cancer Management and Research 2019, 11:3253-3264

Published Date: 15 April 2019